AI and genome engineering: new directions in biology
Dr Leopold Parts, Group Leader at the Wellcome Sanger Institute, studies the effects of DNA mutations by engineering variation in cells. After almost 10 years at Sanger, he has worked across different research areas and experienced significant changes in the field of biology. We spoke with Leo to hear his vision for the role of AI in enhancing gene editing and how it may revolutionise generative and synthetic genomics.



